Overview

• The European Commission searched Sanofi facilities as it investigates suspected anti-competitive practices in seasonal influenza vaccines, including possible abuse of a dominant position.
• Sanofi confirmed the inspections, said it believes it complied with EU rules, and pledged full cooperation with the Commission.
• The Commission emphasized that the inspections do not indicate guilt and that no formal case has been opened.
• Unannounced searches are a standard first move in EU competition inquiries and can lead to fines if violations are established.
• Sanofi shares dipped briefly on the news before recovering, and the company reported about €41 billion in revenue last year.